Intrexon rises 11.1%

Ziopharm Ad-RTS-IL-12 study shows precise control of IL-12 gene expression level Ziopharm Oncology announced results demonstrating the potent anti-tumor and anti-cancer stem cell, or CTC, effects of Ad-RTS-IL-12 in a glioma model, and in other preclinical and clinical settings.

http://ift.tt/1wnFnhf